DEBT (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
	May 31, 2023	Feb. 28, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Note payable			$ 663,111		$ 663,111
Debt balance			99,162		99,162		$ 184,355
Conversion of value issued							3,512,747
Gain on extinguishment of the debt						$ 627,591
Convertible Notes Payable [Member]
Debt Instrument [Line Items]
Note payable							$ 69,250
Interest rate			8.00%		8.00%		8.00%	7.00%
Convertible note payable related party									$ 25,000
Convertible into common stock									$ 0.001
Convertible note payable			$ 2,046,250		$ 2,046,250		$ 1,461,000	$ 1,175,000
Conversion of shares issued								10,000
Conversion of value issued								$ 25,000
Converted amount								94,959
Notes payable issued							$ 1,075,000	$ 386,000
Common stock at a minimum price							$ 0.10
Notes payable plus accrued interest							$ 2,250,000
Converted shares							6,214,355
Gain on extinguishment of the debt							$ 627,592
Derivative liability							3,512,747
Convertible term notes payable							386,000
Maturity date					Jan. 27, 2024
Discount rate			35.00%		35.00%
Notes Payable [Member]
Debt Instrument [Line Items]
Purchase price		$ 450,000
Debt discount		$ 389,046
Repayment debt					$ 106,500		106,500
Debt balance			$ 343,500		343,500		343,500
Installments paid			10,500		$ 10,500
Imputed interest rate					7.00%
Note payable							100,000
Interest expense							10,000
Repayment of notes payable							50,000
Cash converted							60,000
Note payable related party							$ 15,000
Interest rate							7.00%
Note payable				$ 100,000		$ 100,000
Notes Payable [Member] | K A M Biotechnology [Member]
Debt Instrument [Line Items]
Debt discount	$ 762,273
Repayment debt					$ 663,112
Installments paid			25,000		25,000
Acquisition price	$ 800,000
Debt balance			$ 136,889		$ 136,889